Benign non-familial infantile seizures

Benign non-familial infantile seizures (also known as benign sporadic infantile seizures or benign infantile epilepsy, non-familial) is a self-limited epilepsy syndrome that occurs in otherwise healthy infants, typically between 3 and 20 months of age, with a peak around 5 to 6 months. Unlike the familial form, there is no identifiable family history of infantile seizures. The condition primarily affects the central nervous system, manifesting as clusters of focal seizures that may secondarily generalize. Seizures often occur in clusters over one to several days and may include motor arrest, staring, cyanosis, limb jerking, and head or eye deviation. Between seizure episodes, infants appear neurologically normal. The interictal electroencephalogram (EEG) is typically normal, and brain neuroimaging studies (MRI) show no structural abnormalities. The diagnosis is made clinically after excluding other causes of seizures in infancy, such as infections, metabolic disorders, and structural brain lesions. The prognosis is excellent — seizures generally respond well to antiseizure medications and spontaneously remit, usually within weeks to months. Psychomotor development remains normal in the vast majority of affected children. Treatment typically involves short-term use of antiepileptic drugs such as carbamazepine or valproate, though some clinicians may choose observation alone given the self-limited nature of the condition. Medication is usually successfully withdrawn after a seizure-free period, and long-term neurodevelopmental outcomes are favorable.

Common questions about Benign non-familial infantile seizures